160 related articles for article (PubMed ID: 22208968)
41. Predictors of local failure in early laryngeal cancer.
Lohynska R; Slavicek A; Bahanan A; Novakova P
Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
[TBL] [Abstract][Full Text] [Related]
42. Management for stage II glottic carcinoma: radiation therapy or surgery.
Chatani M; Yoshinobu M; Masaki N; Yoshino K
Strahlenther Onkol; 1996 Dec; 172(12):664-8. PubMed ID: 8972751
[TBL] [Abstract][Full Text] [Related]
43. Prognostic factors of glottic carcinomas treated with radiation therapy: value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging system.
Murakami R; Nishimura R; Baba Y; Furusawa M; Ogata N; Yumoto E; Yamashita Y
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):471-5. PubMed ID: 15667969
[TBL] [Abstract][Full Text] [Related]
44. P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer.
Narayana A; Vaughan AT; Kathuria S; Fisher SG; Walter SA; Reddy SP
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):21-6. PubMed ID: 10656367
[TBL] [Abstract][Full Text] [Related]
45. Prognostic role of epidermal growth factor-like domain 7 protein expression in laryngeal squamous cell carcinoma.
Li JJ; Yang XM; Wang SH; Tang QL
J Laryngol Otol; 2011 Nov; 125(11):1152-7. PubMed ID: 21899785
[TBL] [Abstract][Full Text] [Related]
46. Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue.
Krecicki T; Smigiel R; Fraczek M; Kowalczyk M; Sasiadek MM
J Laryngol Otol; 2004 Sep; 118(9):676-80. PubMed ID: 15509364
[TBL] [Abstract][Full Text] [Related]
47. Histologic grading of malignancy and prognosis in glottic carcinoma of the larynx.
Jakobsson PA
Can J Otolaryngol; 1975; 4(5):885-92. PubMed ID: 1203794
[TBL] [Abstract][Full Text] [Related]
48. Angiogenesis and lymphangiogenesis in early-stage laryngeal carcinoma: Prognostic implications.
Bolzoni Villaret A; Barbieri D; Peretti G; Schreiber A; Fisogni S; Lonardi S; Facchetti F; Nicolai P
Head Neck; 2013 Aug; 35(8):1132-7. PubMed ID: 22907864
[TBL] [Abstract][Full Text] [Related]
49. Expression of cell cycle associated proteins influences radiocurability of T2N0 squamous cell carcinoma of the larynx.
Rafferty M; Helliwell TR; Husband DJ; Fenton J; Jones TM; Jones AS
Oral Oncol; 2008 Oct; 44(10):975-81. PubMed ID: 18329328
[TBL] [Abstract][Full Text] [Related]
50. Cortactin expression predicts poor survival in laryngeal carcinoma.
Gibcus JH; Mastik MF; Menkema L; de Bock GH; Kluin PM; Schuuring E; van der Wal JE
Br J Cancer; 2008 Mar; 98(5):950-5. PubMed ID: 18268491
[TBL] [Abstract][Full Text] [Related]
51. [Prognostic significance of cyclin D1 and cyclin B expression in laryngeal squamous cell carcinomas treated with radiotherapy].
Dupla D; Fraczek M; Krecicki T; Woźniak Z
Otolaryngol Pol; 2009; 63(2):136-40. PubMed ID: 19681484
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas.
Sakashita T; Homma A; Suzuki S; Hatakeyama H; Kano S; Mizumachi T; Oridate N; Fukuda S
Acta Otolaryngol; 2013 Sep; 133(9):984-91. PubMed ID: 23692432
[TBL] [Abstract][Full Text] [Related]
53. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx.
Fein DA; Lee WR; Hanlon AL; Ridge JA; Langer CJ; Curran WJ; Coia LR
J Clin Oncol; 1995 Aug; 13(8):2077-83. PubMed ID: 7636551
[TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of cyclin D1 protein levels in early-stage larynx cancer treated with primary radiation.
Yoo SS; Carter D; Turner BC; Sasaki CT; Son YH; Wilson LD; Glazer PM; Haffty BG
Int J Cancer; 2000 Feb; 90(1):22-8. PubMed ID: 10725854
[TBL] [Abstract][Full Text] [Related]
55. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx?
Fein DA; Lee WR; Hanlon AL; Ridge JA; Curran WJ; Coia LR
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):823-31. PubMed ID: 8598359
[TBL] [Abstract][Full Text] [Related]
56. The value of insulin-like growth factor-1 receptor for predicting early glottic carcinoma response to radiotherapy.
Matsumoto F; Ohba S; Fujimaki M; Ikeda K
Auris Nasus Larynx; 2016 Aug; 43(4):440-5. PubMed ID: 26739949
[TBL] [Abstract][Full Text] [Related]
57. Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy.
Douglas CM; Bernstein JM; Ormston VE; Hall RC; Merve A; Swindell R; Valentine HR; Slevin NJ; West CM; Homer JJ
Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):59-65. PubMed ID: 22841149
[TBL] [Abstract][Full Text] [Related]
58. The role of protein p16(INK4a) in glottic laryngeal squamous cell carcinoma.
Kalfert D; Celakovsky P; Laco J; Ludvikova M
Pathol Oncol Res; 2014 Oct; 20(4):909-15. PubMed ID: 24760498
[TBL] [Abstract][Full Text] [Related]
59. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control.
Warde P; O'Sullivan B; Bristow RG; Panzarella T; Keane TJ; Gullane PJ; Witterick IP; Payne D; Liu FF; McLean M; Waldron J; Cummings BJ
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):347-53. PubMed ID: 9607350
[TBL] [Abstract][Full Text] [Related]
60. G1/S-specific cyclin-D1 might be a prognostic biomarker for patients with laryngeal squamous cell carcinoma.
Zhang YY; Xu ZN; Wang JX; Wei DM; Pan XL
Asian Pac J Cancer Prev; 2012; 13(5):2133-7. PubMed ID: 22901182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
